These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 8013320

  • 1. [Treatment with terfenadine and ketoconazole or itraconazole can cause torsades de pointes ventricular tachycardia].
    Pohjola-Sintonen S.
    Duodecim; 1993; 109(2):164-6. PubMed ID: 8013320
    [No Abstract] [Full Text] [Related]

  • 2. Erythromycin and ketoconazole (Nizoral) associated with terfenadine (Seldane)-induced ventricular arrhythmias.
    Wynn RL.
    Gen Dent; 1993; 41(1):27-9. PubMed ID: 7489857
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Torsades de pointes occurring in association with terfenadine use.
    Mathews DR, McNutt B, Okerholm R, Flicker M, McBride G.
    JAMA; 1991 Nov 06; 266(17):2375-6. PubMed ID: 1920744
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Strategic proposals to avoid drug interactions during drug development: a lesson from a terfenadine-related drug interaction.
    Ishizaki T.
    J Toxicol Sci; 1996 Dec 06; 21(5):301-3. PubMed ID: 9035041
    [No Abstract] [Full Text] [Related]

  • 11. Cardiovascular toxicity of antihistamines.
    Smith SJ.
    Otolaryngol Head Neck Surg; 1994 Sep 06; 111(3 Pt 2):348-54. PubMed ID: 7916150
    [Abstract] [Full Text] [Related]

  • 12. Torsades de pointes from terfenadine and sotalol given in combination.
    Feroze H, Suri R, Silverman DI.
    Pacing Clin Electrophysiol; 1996 Oct 06; 19(10):1519-21. PubMed ID: 8904547
    [Abstract] [Full Text] [Related]

  • 13. Some observations on the cardiotoxic and drug interaction profiles of second generation antihistamines as measured in the guinea pig.
    Roberts DJ, Llenas J.
    Arzneimittelforschung; 1996 Aug 06; 46(8):832-3. PubMed ID: 9125289
    [No Abstract] [Full Text] [Related]

  • 14. [Torsades de pointes caused by the association of terfenadine and erythromycin].
    Gully C, Riem R.
    Ann Med Interne (Paris); 1994 Aug 06; 145(4):257-8. PubMed ID: 8092653
    [No Abstract] [Full Text] [Related]

  • 15. [A new cause of torsades de pointes: combination of terfenadine and troleandomycin].
    Fournier P, Pacouret G, Charbonnier B.
    Ann Cardiol Angeiol (Paris); 1993 May 06; 42(5):249-52. PubMed ID: 8368797
    [Abstract] [Full Text] [Related]

  • 16. Terfenadine should be withdrawn from clinical use.
    Khilnani G.
    J Assoc Physicians India; 1999 Sep 06; 47(9):943. PubMed ID: 10778682
    [No Abstract] [Full Text] [Related]

  • 17. The changing face of antihistamines and cardiac adverse drug reactions: a clinical perspective.
    Shaikh WA.
    J Indian Med Assoc; 2000 Jul 06; 98(7):397-9. PubMed ID: 11143865
    [Abstract] [Full Text] [Related]

  • 18. Terfenadine use associated with ventricular dysrhythmias.
    Krasner LM.
    Crit Care Nurse; 1992 Feb 06; 12(2):51-2. PubMed ID: 1544306
    [No Abstract] [Full Text] [Related]

  • 19. Drug-induced torsades de pointes: a possible interaction of terfenadine and erythromycin.
    Biglin KE, Faraon MS, Constance TD, Lieh-Lai M.
    Ann Pharmacother; 1994 Feb 06; 28(2):282. PubMed ID: 8173153
    [No Abstract] [Full Text] [Related]

  • 20. [Extension of QT interval as a consequence of risk factor accumulation--case study].
    Sisáková M, Toman O, Floriánová A, Kadlecová J, Chroust K, Papousek I, Spinar J.
    Vnitr Lek; 2006 Mar 06; 52(3):271-3. PubMed ID: 16722159
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.